[Study of the effects of HSDAD corticosteroid therapy on the diurnal rhythm of 11-OCHS secretion, cortisol metabolism, and calciuria in patients with myasthenia gravis. (Preliminary communication)].
D015062:11-Hydroxycorticosteroids / Q000378:metabolism*; D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D002940:Circadian Rhythm / Q000187:drug effects*; D005448:Fluocortolone / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000503:physiopathology*; D011244:Pregnadienediols / Q000008:administration & dosage*
D015062:11-Hydroxycorticosteroids; D015065:17-Hydroxycorticosteroids; D011244:Pregnadienediols; D005448:Fluocortolone; D006854:Hydrocortisone
Proucavanje utjecaja kortikosteroidne terapije HSDAD tipa na dnevni ritam 11-OHCS sekrecije, metabolite kortizola te kalciuriju u bolesnika s miastenijom gravis. (Preliminarno saopćenje).